Literature DB >> 1587790

Molecular and enzymatic properties of furin, a Kex2-like endoprotease involved in precursor cleavage at Arg-X-Lys/Arg-Arg sites.

K Hatsuzawa1, K Murakami, K Nakayama.   

Abstract

We have recently shown that furin, a mammalian homologue of the yeast precursor-processing endoprotease Kex2, is involved in precursor cleavage at sites marked by the Arg-X-Lys/Arg-Arg motif within the constitutive secretory pathway. In this study, we analyzed molecular and enzymatic properties of furin expressed in Chinese hamster ovary cells using gene transfer techniques. COOH-terminal truncation analyses indicate that the polypeptide region significantly conserved among the Kex2 family members is required for the endoprotease activity of furin, while the COOH-terminal unconserved region containing the Cys-rich domain and the transmembrane domain is dispensable. A mutant of furin truncated up to the transmembrane domain from the COOH-terminus was secreted into the culture medium as an active form. The sequence requirements for precursor cleavage of this truncated furin determined in vitro were similar to those of wild-type furin determined by expression studies in cultured cells. It had a strong resemblance to the Kex2 protease in the inhibitor profile and pH dependency. These observations support the notion that furin is the endogenous endoprotease involved in precursor cleavage at Arg-X-Lys/Arg-Arg sites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587790     DOI: 10.1093/oxfordjournals.jbchem.a123753

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  27 in total

1.  'Shed' furin: mapping of the cleavage determinants and identification of its C-terminus.

Authors:  B Plaimauer; G Mohr; W Wernhart; M Himmelspach; F Dorner; U Schlokat
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

2.  Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage.

Authors:  E D Anderson; J K VanSlyke; C D Thulin; F Jean; G Thomas
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

3.  Changing the protease specificity for activation of a flavivirus, tick-borne encephalitis virus.

Authors:  Wolfgang Fischl; Sigrid Elshuber; Sabrina Schrauf; Christian W Mandl
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

4.  Subunit cleavage of mosquito pro-vitellogenin by a subtilisin-like convertase.

Authors:  J S Chen; A S Raikhel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation.

Authors:  C M Smas; L Chen; H S Sul
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

6.  The integrity of the RRGDL sequence of the proprotein convertase PC1 is critical for its zymogen and C-terminal processing and for its cellular trafficking.

Authors:  J Lusson; S Benjannet; J Hamelin; D Savaria; M Chrétien; N G Seidah
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

7.  Deletion of various carboxy-terminal domains of Lactococcus lactis SK11 proteinase: effects on activity, specificity, and stability of the truncated enzyme.

Authors:  P G Bruinenberg; W M De Vos; R J Siezen
Journal:  Appl Environ Microbiol       Date:  2000-07       Impact factor: 4.792

Review 8.  Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins.

Authors:  K Nakayama
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

9.  Identification of a 50-kDa systemin-binding protein in tomato plasma membranes having Kex2p-like properties.

Authors:  A Schaller; C A Ryan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

10.  A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1.

Authors:  Y Ohnishi; T Shioda; K Nakayama; S Iwata; B Gotoh; M Hamaguchi; Y Nagai
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.